English | Español
Press release submission | Jul 2, 2019

BIOGEN, INC.: Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients
Press release submission | Jul 1, 2019

EXPERIMENTAL BIOLOGY AND MEDICINE: A New Target for the Treatment of Idiopathic Pulmonary Fibrosis
Press release submission | Jun 28, 2019

AJ VACCINES: Will Contribute to Global Polio Eradication With its Innovative Vaccine Picovax
Press release submission | Jun 27, 2019

CHILDREN'S NATIONAL HEALTH SYSTEM: Children's National study identifies potential pupillary biomarker for pediatric bowel and bladder dysfunction (BBD) that could improve diagnosis and intervention
Press release submission | Jun 21, 2019

FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH: New research provides insight into immunity of lupus patients
Press release submission | Jun 20, 2019

SUMMIT MEDICAL GROUP: CityMD and Summit Medical Group Announce Plans to Merge to Deliver an Unparalleled Patient Care Experience
Press release submission | Jun 14, 2019

JOHNSON & JOHNSON: Janssen reports top-line Phase 3 results for TREMFYA® (guselkumab) in adults with active psoriatic arthritis
Press release submission | Jun 14, 2019

BERGENBIO ASA: BerGenBio Presents Preliminary Phase II Clinical Data at EHA 24: Bemcentinib in Combination With Low Dose Chemotherapy Yields Durable Responses in AML Patients Unfit for Intensive Chemotherapy

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’